Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Skarka

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 20, 2021
Pyridinium-2-carbaldoximes with quinolinium carboxamide moiety are simultaneous reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by nerve agent surrogatesHyun Myung Lee, Rudolf Andrys, Jakub Jonczyk, et al.
Bioorganic Chemistry|April 23, 2026
The structure-activity relationship study of torkinib derivatives as mTOR inhibitors with senolytic and STAT3 inhibitory activitiesPatrik Oleksak, David Rysanek, Marketa Vancurova, et al.
European Journal of Medicinal Chemistry|June 30, 2023
Development of submicromolar 17β-HSD10 inhibitors and their in vitro and in vivo evaluationOndrej Benek, Michaela Vaskova, Marketa Miskerikova, et al.
Cancer Cell International|May 7, 2026
In silico screening, synthesis, and biological evaluation of pyrazolopyrimidine-derived mTOR inhibitors for anticancer and senomorphic effectsDavid Rysanek, Zofia Chrienova, Dorota Stary, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 2023
Frentizole derivatives with mTOR inhibiting and senomorphic propertiesZofia Chrienova, David Rysanek, Josef Novak, et al.
Journal of Medicinal Chemistry|August 8, 2025
Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38α Mitogen-Activated Protein Kinase InhibitorsSvit Ferjančič Benetik, Matic Proj, Damijan Knez, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 20, 2021
Pyridinium-2-carbaldoximes with quinolinium carboxamide moiety are simultaneous reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by nerve agent surrogatesHyun Myung Lee, Rudolf Andrys, Jakub Jonczyk, et al.
Bioorganic Chemistry|April 23, 2026
The structure-activity relationship study of torkinib derivatives as mTOR inhibitors with senolytic and STAT3 inhibitory activitiesPatrik Oleksak, David Rysanek, Marketa Vancurova, et al.
European Journal of Medicinal Chemistry|June 30, 2023
Development of submicromolar 17β-HSD10 inhibitors and their in vitro and in vivo evaluationOndrej Benek, Michaela Vaskova, Marketa Miskerikova, et al.
Cancer Cell International|May 7, 2026
In silico screening, synthesis, and biological evaluation of pyrazolopyrimidine-derived mTOR inhibitors for anticancer and senomorphic effectsDavid Rysanek, Zofia Chrienova, Dorota Stary, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 2023
Frentizole derivatives with mTOR inhibiting and senomorphic propertiesZofia Chrienova, David Rysanek, Josef Novak, et al.
Journal of Medicinal Chemistry|August 8, 2025
Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38α Mitogen-Activated Protein Kinase InhibitorsSvit Ferjančič Benetik, Matic Proj, Damijan Knez, et al.
Pageof 4